These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37635696)

  • 21. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
    Uebelacker LA; Bailey G; Herman D; Anderson B; Stein M
    J Subst Abuse Treat; 2016 Jul; 66():48-53. PubMed ID: 27211996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.
    Evans EA; Yoo C; Huang D; Saxon AJ; Hser YI
    J Subst Abuse Treat; 2019 Nov; 106():19-28. PubMed ID: 31540607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatment of opioid use disorder in pregnancy.
    Rodriguez CE; Klie KA
    Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
    Pro G; Utter J; Haberstroh S; Baldwin JA
    Drug Alcohol Depend; 2020 Apr; 209():107952. PubMed ID: 32172130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 28. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
    Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
    J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
    Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L
    Mol Psychiatry; 2019 Dec; 24(12):1868-1883. PubMed ID: 29934549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.
    Leiner C; Cody T; Mullins N; Ramage M; Ostrach BMM
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):143. PubMed ID: 33596843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
    Shea CM; Gertner AK; Green SL
    Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program.
    Reed MK; Smith KR; Ciocco F; Hass RW; Cox AL; Kelly EL; Weinstein LC
    Subst Abuse Treat Prev Policy; 2023 Jan; 18(1):4. PubMed ID: 36641478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
    Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
    J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
    [No Abstract]   [Full Text] [Related]  

  • 34. "They're making it so hard for people to get help:" Motivations for non-prescribed buprenorphine use in a time of treatment expansion.
    McLean K; Kavanaugh PR
    Int J Drug Policy; 2019 Sep; 71():118-124. PubMed ID: 31330267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing Primary Care Utilization of Medication-Assisted Treatment (MAT) for Opioid Use Disorder.
    Gardner-Buckshaw SL; Perzynski AT; Spieth R; Khaira P; Delos Reyes C; Novak L; Kropp D; Caron A; Boltri JM
    J Am Board Fam Med; 2023 Apr; 36(2):251-266. PubMed ID: 36948541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment.
    Justesen K; A Hooker S; Sherman MD; Lonergan-Cullum M; Nissly T; Levy R
    J Am Board Fam Med; 2020; 33(6):848-857. PubMed ID: 33219064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol.
    Sanger N; Shahid H; Dennis BB; Hudson J; Marsh D; Sanger S; Worster A; Teed R; Rieb L; Tugwell P; Hutton B; Shea B; Beaton D; Corace K; Rice D; Maxwell L; Samaan MC; de Souza RJ; Thabane L; Samaan Z
    BMJ Open; 2018 Dec; 8(12):e025059. PubMed ID: 30518592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.
    Levin FR; Bisaga A; Sullivan MA; Williams AR; Cates-Wessel K
    Am J Addict; 2016 Dec; 25(8):603-609. PubMed ID: 28051841
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.